Sola Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOLA PHARMS
SOLA PHARMS has four approved drugs.
Summary for Sola Pharms
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Sola Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sola Pharms | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209677-001 | Jun 17, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sola Pharms | DIMETHYL FUMARATE | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 210436-001 | Mar 26, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sola Pharms | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 215417-001 | Apr 15, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sola Pharms | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 216824-001 | May 19, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sola Pharms | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209677-002 | Sep 28, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
